A

AstraZeneca

Global pharmaceutical company developing prescription medicines

Global Pricing & Access Lead - Rare Haematology

Corporate StrategyPosted on Nov 11
Full-timeBarcelona, SpainNo salary listed

About the Job

Requirements

  • Demonstrated leadership and ability to take initiative and consistently deliver high-quality work in rare-disease evidence contexts with greater uncertainty and competition.
  • Ability to communicate effectively and translate science into compelling payer value stories for company leadership and identified stakeholders, collaborating closely with local market access colleagues and the Commercial Launch Excellence function.
  • Experience developing evidence-based innovative value solutions, such as working with local payers in the EU or commercial customers in the US.
  • A relevant graduate degree, such as a PhD, PharmD, Biomedical Sciences, business, or economics qualification.
  • Highly specialized rare disease and/or Haematology market access experience.
  • More than 6 years of relevant drug development and/or commercialization experience within the pharmaceutical or medical industry.
  • Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers in strategic markets.
  • Ability to use a computer, communicate by phone, video, and electronic messaging, engage in problem-solving, analysis, and dialogue, collaborate with others, and maintain general availability during standard business hours.

Responsibilities

  • Lead and drive cross-functional development of a clear, differentiated value proposition for PNH and HSCT-TMA, influencing without formal authority and navigating complex organizational environments.
  • Collaborate with cross-functional teams to incorporate evidence-generation plans and real-world evidence into the value proposition to reduce payer uncertainty and optimize patient access, including obtaining timely country input in priority target countries.
  • Support the Global Marketing and Market Access Commercial team in advancing PNH lifecycle management through governance milestones, focusing on market access potential, evidence requirements, and target product profile requirements.
  • Lead development of global market access and pricing strategies and support implementation in partnership with country access representatives.
  • Assess pricing and reimbursement risks and opportunities for Haematology and develop and implement mitigation actions.
  • Create and roll out strategic value, access, and pricing communication tools and materials for PNH and HSCT-TMA to support local pricing and reimbursement submissions and negotiations, including pricing frameworks, negotiation strategies, and market access toolkits aligned with the enterprise-wide launch framework.
  • Lead updates to the global PNH reimbursement dossier and cross-functional Haematology market access readiness plans in collaboration with key countries and HEOR, Medical, and Commercial support functions.
  • Represent the Global Value Access and Pricing perspective and strategy across cross-functional teams, including the Global Value Sub-Team and Global Launch Team.
  • Provide strategic updates, guidance, and materials to local teams as required.
  • Lead the monthly Haematology, Nephrology, and Transplant payer working group to align global payer strategies, share current pricing and reimbursement insights, and promote best-practice sharing across countries.
  • Ensure the patient perspective is incorporated into market access strategies and recommend approaches that support the patient voice in key payer negotiations.
  • Support development of the Haematology pricing strategy.
  • Conduct payer and value assessments to identify market-specific pricing and reimbursement drivers and barriers.
  • Develop differentiated value propositions and use findings to inform evidence-generation plans, regulatory strategy, and development decisions.
  • Partner with the Global Value Access and Pricing Expansion Markets team to lead and co-create market-level pricing and reimbursement strategies and support submissions and negotiations in prioritized markets.
  • Review pricing and reimbursement cases submitted by local markets and support country teams in maintaining product value while enabling local access.
  • Work closely with country access representatives and, where relevant, the International Shared Markets Global Value Access and Pricing team.
  • Provide strategic input into access and pricing assumptions to support accurate long-term and mid-term plan assumptions.
  • Monitor and communicate competitor market access and pricing developments.
  • Communicate with Global Marketing and Market Access Commercial senior leadership and other key stakeholders, particularly on Haematology launches and the PNH lifecycle management pricing and reimbursement strategy.

About the Company

AstraZeneca

Global pharmaceutical company developing prescription medicines

AstraZeneca develops and markets prescription medicines and vaccines worldwide, with a focus on oncology, cardiovascular/metabolic, respiratory, and infectious diseases. Its products work by targeting specific biological pathways or cells, using small-molecule therapies, biologics, and vaccines to treat diseases or prevent infections. It differentiates itself through its dual heritage from Sweden and the UK, a broad pipeline, and strong R&D and collaborations that move from discovery to patient access. Its goal is to improve people’s health by discovering, developing, and delivering medicines and vaccines to patients worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913

Recently Posted Jobs

Explore more opportunities at AstraZeneca

See more jobs